Hematologists near Hoboken, NJ

Biography: Nicholas Cacciola-Price, NP is a Radiation Oncology Specialist who practices in New York, NY. Nicholas Cacciola-Price, NP is affiliated with Newyork-Presbyterian.

Biography: Dr. Lisa Roth is an Assistant Professor in the Departments of Pediatrics and Medicine at Weill Cornell Medicine. She is also the Director of the Adolescent and Young Adult Lymphoma Program at Weill Cornell Medicine/New York Presbyterian Hospital. Dr. Roth has been named the Charles, Lillian, and Betty Neuwirth Clinical Scholar in Pediatric Oncology. Dr. Roth completed her undergraduate work at Duke University. She received her medical degree from New York University School of Medicine. Dr. Roth conducted her residency at NewYork-Presbyterian/Weill Cornell and her fellowship in pediatric hematology/oncology at Memorial Sloan-Kettering Cancer Center and NewYork-Presbyterian where she served as chief fellow. Dr. Roth specializes in treating children, adolescents and young adults with lymphoma and leukemia. She is a member of the Children's Oncology Group and an active participant in Hodgkin lymphoma and non-Hodgkin lymphoma clinical trials. She is also a member of the Weill Cornell Center for Lymphoma, a group which is internationally recognized for it's leadership in the treatment of patients with lymphoma. Dr. Roth's research focuses on identifying new treatments for children with lymphoma. She is particularly interested identifying novel targeted therapies. Targeted therapies may be less toxic than conventional chemotherapy and may be able to rescue those patients with chemotherapy-resistant disease. Dr. Roth has been recognized for her work with awards from the National Institutes of Health (NIH), the Lymphoma Research Foundation, Hyundai Hope on Wheels Foundation, and the St. Baldrick's Foundation. For More Videos, please see below: OR-Live: Treating AYA Patients with Hodgkins Lymphoma (5/10/2017)https://www.youtube.com/watch?v=PT-Qwg2EvqgLymphoma Cancer Treatment NY - Weill Cornell Dr. Roth In the News: Taking Away the Toll (12/2015)http://www.nyrr.org/races-and-events/2016/nyrr-new-york-mini-10k/lisa-roth

Biography: Alana Nguyen, MD PhD, is an Assistant Professor in the Division of Hematology and Oncology at Weill Cornell Medicine/NewYork-Presbyterian Hospital.Dr. Nguyen received her MD from Boston University in Boston, Massachusetts and herPhD from McGill University in Montreal, Canada. She went on to complete her postgraduate medical training in Internal Medicine at the Mount Sinai Hospital in New York City. After her residency, she entered fellowship training in Medical Oncology at Columbia University/New York-Presbyterian Hospital in the Physician-Scientist Pathway.Dr. Nguyen sees patients with malignancies of the digestive tract in her clinical practice.In addition, her research focuses on drug development based on biological understanding of therapy resistance. She received a Women Who Conquer Cancer Award from the American Society for Clinical Oncology and its Conquer Cancer Foundation for her work on a 3-dimensional culture model of patient tumors to predict for patients' response to chemotherapy and immunotherapy. Using this innovative model, her current research will focus on understanding the tumor microenvironment of pancreatic cancer, and how this tumor microenvironment participates in drug evasion.

Care Philosophy: nbsp; It takes a village to achieve the best care of patients in their battle against complicated blood disorders I am privileged to work in a world class medical institution which not only assures a multidisciplinary approach for patient treatment

Biography: Nora Chokr, M.D., is an Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine/ NewYork-Presbyterian Hospital. She specializes in the care of patients with blood disorders who are in need of bone marrow or stem cell transplantation or cellular-based therapies, like chimeric antigen receptor (CAR) T-cell therapy. Dr. Chokr received her medical degree from the American University of Beirut Medical Center in Lebanon in 2015. She completed her Internal Medicine residency at Yale New Haven Hospital and her Hematology/Oncology fellowship at SUNY Downstate Medical Center, where she served as a Chief Fellow. Subsequently, she completed an advanced fellowship in Bone Marrow Transplantation and Immune Effector Cell Therapy at Weill Cornell Medicine (WCM)/NewYork-Presbyterian (NYP) Hospital. Upon completion of this advanced fellowship training, Dr. Chokr was recruited to join the faculty of the WCM/NYP Bone Marrow Transplantation Program. Dr. Chokr's main research interests focus on increasing transplant access and optimizing outcomes in older patients. Her interests also include the prevention of disease relapse and graft vs host disease after transplant. Dr. Chokr is an investigator for several clinical trials that aim to advance the field. She has publications in leading international peer-reviewed journals, and is a member of the American Society of Hematology (ASH), American Society for Transplantation and Cellular Therapy (ASTCT), ASTCT Aging Special Interest Group, Cancer and Aging Research Group (CARG). Dr. Chokr is also involved in teaching medical students, residents and fellows.

Biography: Juliet Barker, MBBS (Hons), FRACP, is an Australian trained hematologist. Having been an Attending Member and Physician at Memorial Sloan Kettering Cancer Center (MSKCC) and the Director of the MSKCC Cord Blood (CB) Transplantation Program, Dr. Barker has been recruited to Weill Cornell Medicine and NewYork-Presbyterian Hospital as the Director of the Bone Marrow Transplant and Cellular Therapy Program.Over the last 25 years, Dr. Barker has worked to expand transplant access to minority patients with hematologic malignancies and has demonstrated the ability of cord blood transplantation to provide curative therapy for such populations without suitable adult donors. Dr. Barker's work in this area has been internationally recognized and she has published extensively concerning novel strategies to optimize access to donor transplants and cord blood transplant outcomes. Additionally, she has a special focus on optimizing complex health care delivery such as hematopoietic stem cell transplantation in under-served populations. Dr. Barker has advised the National Marrow Donor Program (NMDP) and is a member of the Advisory Council on Blood Stem Cell Transplantation to the Health Resources and Services Administration of the U.S. government. She has served on the American Society for Transplantation and Cellular Therapy (ASTCT) Board and led the national ASTCT Cord Blood Special Interest Group. Having previously served as Associate Vice Chair, Faculty Development, in the Department of Medicine at MSKCC, Dr. Barkeralso has a keen interest in academic mentorship.

Care Philosophy: My philosophy is simple: the patient comes first. As part of the Genitourinary Oncology Program at Weill Cornell Medicine, I am committed to delivering the best care to my patients. Our world-class multidisciplinary team ensures that we treat the patient as a whole, not just the cancer. I am driven by the desire to improve therapy of urological malignancies by identifying the genetic "Achilles heel" of each patient's cancer. Through my research, I am committed to developing "precision medicine" approaches and conducting clinical trials for treatment of bladder cancer and other genitourinary malignancies.

Biography: Rohit K. Jain MD, MPH is an Associate Professor of Medicine at Weill Cornell Medicine and Attending Physician at NewYork-Presbyterian Hospital- Weill Cornell Medical Center. Dr. Jain earned his medical degree at Topiwala National Medical College and B.Y.L. Nair Charitable Hospital, Mumbai, India. He completed Internal Medicine Residency at Johns Hopkins University/Sinai Hospital of Baltimore and Hematology-Oncology Fellowship at Roswell Park Cancer Institute University at Buffalo, New York. After fellowship, Dr. Jain, joined the H. Lee Moffitt Cancer Center in Tampa, Florida as Assistant Professor, and was instrumental in building the bladder cancer program. Dr. Jain was selected as Castle Connolly "Top Doctor" for 2024, as well as one of America's Best Prostate Cancer Oncologist by Newsweek magazine in 2024. Dr. Jain was recruited to Weill Cornell Medicine (WCM) in 2024. He cares for patients with bladder (urothelial), kidney (renal), prostate and testicular cancers, with a major focus in urothelial cancers. His research interests are primarily in urothelial and prostate cancers. Dr. Jain is involved in biomarker research as well as developing innovative clinical trials for patients, and he has received funding from the National Cancer Institute (NCI).

Biography: Amer Assal MD is a board certified medical oncologist and hematologist who specializes in the use of autologous and allogeneic bone marrow stem cell transplantation for the treatment of multiple myeloma, leukemia, lymphoma, myelodysplastic syndromes and other bone marrow disorders. Dr. Assal completed his medical education and internal medicine training at NYU School of Medicine. He was also a hospitalist in the department of medicine at Memorial Sloan Kettering Cancer Center caring for patients with a variety of cancer diagnoses, including stem cell transplant patients. Dr. Assal completed a fellowship in hematology and medical oncology at Albert Einstein College of Medicine where he also served as chief fellow. He finally completed a fellowship in blood and marrow stem cell transplantation at Memorial Sloan Kettering Cancer Center. His research interests center around improving outcomes of stem cell transplantation and the diseases it is used to treat. He has a particular interest in immunotherapy and studying ways to harness the immune system to attack tumor cells, while at the same time decreasing the risk of graft versus host disease. He is also interested in studying therapeutic interventions to prevent and treat relapse of disease after stem cell transplantation. He has presented his research at several national conferences and was awarded an American Society of Hematology Abstract Achievement award for his research.

Biography: Michal Bar-Natan, MD, is Interim Assistant Professor of Medicine and a member of the Leukemia Program at Weill Cornell Medicine and NewYork-Presbyterian Hospital in New York City.Dr. Bar-Natan graduated cum laude from the Sackler School of Medicine. She completed her Internal Medicine Residency at Sheba Medical Center and her Fellowship in Hematology and Medical Oncology at NYU Langone Health.In addition to her clinical fellowship training, Dr. Bar-Natan completed a research fellowship at Dana Farber Cancer Institute and Brigham and Women's Hospital (Harvard Medical School) with a focus on the role that signal transducer and activator of transcription (STAT) proteins play in the development and treatment of myeloproliferative neoplasms (MPNs) and leukemias.Prior to this position Dr. Bar-Natan served as Associate Professor of Medicine at the Icahn School of Medicine at Mt. Sinai, an Attending Physician with the Center of Excellence for Blood Cancers and Myeloid Disorders, and as the leader of the Acute Lymphoblastic Leukemia programat the Mt. Sinai Tisch Cancer Institute.Dr. Bar-Natan's focus is on translational research in malignant hematology, particularly myeloid malignancies and acute lymphoblastic leukemia, and the development of investigator-initiated clinical trials for patients with these conditions. She leads early phase clinical trials implementing new therapeutic approaches, such as immunotherapies and combination therapies, and serves as the PI and co-investigator on many clinical trials for acute leukemias and myeloproliferative neoplasms.

Biography: Dr. Canaani received his MD from The University of Tel Aviv School of Medicine followed by residency in Internal Medicine at The Tel Aviv Medical Center, and laboratory research at the Weizmann Institute of Science. He completed a clinical fellowship in hematology/oncology at the Hospital of the University of Pennsylvania and subsequently served as the director of the Adult Leukemia Program of The Sheba Medical Center. He is an Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine caring for patients with blood cancers as part of the NewYork-Presbyterian Medical Group Brooklyn.

Biography: Dr. Charles Shapiro, MD is a Hematology Specialist who practices in New York, NY. He is 68 years old and has been practicing for 41 years. Dr. Charles Shapiro, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Surabhi Batra, MD is a Pediatric Hematology-Oncology Specialist who practices in Newark, NJ. She is 43 years old. Dr. Surabhi Batra, MD is affiliated with Cooperman Barnabas Medical Center and Newark Beth Israel Medical Center.

Biography: Dr. Harini Rao, MD is an Oncology Specialist who practices in Newark, NJ. She is 45 years old and has been practicing for 17 years. Dr. Harini Rao, MD is affiliated with Cooperman Barnabas Medical Center and Newark Beth Israel Medical Center.

Biography: Dr. Marianna Debenedictis, MD is a Pediatric Hematology-Oncology Specialist who practices in Newark, NJ. She is 44 years old and has been practicing for 11 years. Dr. Marianna Debenedictis, MD is affiliated with Newark Beth Israel Medical Center.

Care Philosophy: I am a medical oncologist with interests in lung cancers, head and neck cancers, and pancreatic cancers. Its important to me that patients feel they are not alone in their fight against cancer. I have a strong interest in clinical trial and providing patients with the most advanced available care. My goal is to help patients be in control with their health and understand their treatment options.

Biography: Dr. Jorge Gomez, MD is a Hematology Specialist who practices in New York, NY. He is 63 years old and has been practicing for 37 years. Dr. Jorge Gomez, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Joshua Brody, MD is a Hematology Specialist who practices in New York, NY. He is 51 years old and has been practicing for 25 years. Dr. Joshua Brody, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Ronald Hoffman, MD is an Anatomic /amp Clinical Pathology Specialist who practices in New York, NY. He is 80 years old and has been practicing for 54 years. Dr. Ronald Hoffman, MD is affiliated with Mount Sinai Hospital.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Care Philosophy: I believe that it is a privilege to take care of patients who have cancer. Patients deserve to be treated with care and respect. I give my patients the time they need to discuss all of their concerns, without rushing them. My patients have access to my personal cell phone number. Staying current on all of the latest clinical research is important to me, as is collaboration with subspecialists in order to ensure the best possible care.

Biography: Dr. Celina Ang, MD is a Hematology Specialist who practices in New York, NY. She is 46 years old. Dr. Celina Ang, MD is affiliated with Mount Sinai Morningside and Mount Sinai Hospital.

Biography: Dr. Ingham is Assistant Professor of Medicine in the Division of Hematology and Oncology at New York Presbyterian Hospital/Columbia University Medical Center. He received his medical degree from the University of Massachusetts Medical School and completed internship and residency training in Internal Medicine at New York University Medical Center, where he served as Chief Resident. He then completed fellowship training in Hematology and Medical Oncology at New York Presbyterian Hospital/Columbia University Medical Center where he served as Chief Fellow. Dr. Ingham specializes in the care of patients with sarcoma and gastrointestinal cancers and is also an active member of the experimental therapeutics unit. His research focuses on the development and clinical evaluation of new treatments for patients with sarcoma. He leads a National Cancer Institute (NCI) sponsored clinical trial evaluating a new treatment approach for uterine leiomyosarcoma based on research conducted at Columbia University. He also leads several other investigator-initiated clinical trials evaluating new targeted and immunotherapy based treatment approaches for leiomyosarcoma, liposarcoma and other types of sarcoma. He is the author of two recent authoritative reviews on the treatment of sarcoma published in the Journal of Clinical Oncology. He is the recipient of the 2019 Conquer Cancer Foundation of ASCO Career Development Award from the Sarcoma Foundation of America in recognition of his research and was also named a 2019 NextGen Innovator by HemOnc Today, among other awards and honors. His overall goal is to provide patients with compassionate oncologic care and access to the most promising treatment approaches.

Biography: Rajshekhar Chakraborty, MD is an assistant professor of medicine at Columbia University Irving Medical Center in the division of hematology/oncology. After receiving his medical degree from University of Delhi, India, he completed his residency in internal medicine at Icahn School of Medicine at Mount Sinai-Queens Hospital Center. Subsequently, he spent three years as a clinical researcher in plasma cell disorders at the Mayo Clinic, Rochester, followed by fellowship in hematology/oncology at the Cleveland Clinic. During fellowship, he conducted outcomes research with a focus on quality of life and treatment-related toxicities in plasma cell disorders. After fellowship, he started his job as Assistant Professor of Medicine at the Multiple Myeloma and Amyloidosis Program at Columbia University Irving Medical Center. Dr. Chakraborty cares primarily for patients with plasma cells disorders, including multiple myeloma, amyloidosis, MGUS, POEMS syndrome, and Waldenstrom's macroglobulinemia. His research interests include clinical trials and outcomes research in plasma cell disorders.

Biography: My expertise is in pediatric hematology and oncology, with a particular focus on leukemias and lymphomas, or cancers of the blood, bone marrow, or lymph nodes. I am especially interested in chronic myeloid leukemia (CML). Because children are growing and developing, CML treatment and management present unique challengesthe same treatment options that work best for grown-ups may not be the right strategies for kids. I treat children, adolescents, and young adults. I love working with this population and developing long-lasting relationships with my young patients. I am especially passionate about delivering personalized care to each of thembecause no two kids are the same. Diseases like leukemia and lymphoma are challenging for anyone, but they can be especially hard on children. Symptoms like fatigue and joint pain can make it hard to move, play, and act like a kid, and some treatments can have severe side effects. I work to manage children's symptoms and choose the right treatments for their disease, based on their individual needs. Helping these children is the most satisfying goal I can imagine. My research revolves around the treatment of pediatric leukemias and lymphomas. I continue to explore the impact of current treatments, and I collaborate with basic science researchers to translate their breakthroughs into new drug development. I have also been involved in cancer survivorship research. As a professor and the section head of pediatric oncology, I am deeply committed to educating and mentoring medical students, residents, and fellows and helping to prepare the next generation of leaders in pediatric hematology/oncology.

Biography: Margaret T Lee, MD cares for children with blood disorders, such as anemias (sickle cell anemia, thalassemia, and iron deficiency), bleeding (including idiopathic thrombocytopenic purpura [ITP], hemophilia, and von Willebrand disease), and clotting disorders (such as deep vein thrombosis). Dr. Lee's area of interest is a rare group of diseases called vascular anomalies. There is relatively little known about these disorders, and the care of patients with vascular anomalies requires a multidisciplinary group of physicians from several specialties (dermatology, surgery, cardiology, neurology, and hematology/oncology)-all of whom are available at NewYork-Presbyterian/Morgan Stanley Children's Hospital. Hematologists play a role in the medical treatment of vascular tumors and the supportive care of clotting and bleeding complications that are associated with some types of vascular malformations. Dr. Lee is an active participant in the Vascular Anomalies Group at NYP/Morgan Stanley Children's Hospital, as well as the Vascular Anomalies Special Interest Group of the American Society of Pediatric Hematology/Oncology, which is looking at novel therapies for vascular anomalies and their complications.

Biography: Diane George, MD cares for children and adolescents undergoing stem cell transplantation as a treatment for cancer (particularly leukemia and lymphoma), noncancerous blood disorders (like sickle cell anemia), and immunodeficiencies. She specializes in transplantation for patients who don't have a related bone marrow donor, and also takes care of patients undergoing autologous stem cell transplantation for solid tumors. Dr. George was originally attracted to the field of pediatric oncology because she wanted to take on the challenge of fighting pediatric cancer, and stem cell transplantation offers the ultimate cure in select patients. It is a complex medical field, and Dr. George enjoys being able to take care of children with complex medical conditions. Dr. George also conducts clinical research. She is currently evaluating a procedure called "CD34-selected stem cell transplantation" to remove T-cells from donor bone marrow. This approach reduces the risk of graft-versus-host disease (GVHD) - a potential complication of bone marrow transplantation in which T-cells from the donor attack the tissue of the recipient. This approach benefits patients who do not have a well-matched family donor, and it could potentially make bone marrow transplantation an option for more patients. Dr. George is also interested in studying how a patient's immune system rebuilds itself after CD34-selected stem cell transplantation. At NewYork-Presbyterian/Morgan Stanley Children's Hospital, every member of a child's healthcare team shares the same compassion and dedication to helping them get well. Dr. George looks forward each day to the camaraderie, intellectual stimulation, and problem-solving she shares with fellow team members. After being in the field for more than 20 years, Dr. George uses the knowledge and experience she has gained to benefit patients and their families.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Dr. Reshef trained in Hematology, Oncology and Bone Marrow Transplantation and received a Master of Science degree in Translational Research from the University of Pennsylvania. He joined Columbia University in 2015 as Director of Translational Research for the Blood and Marrow Transplantation program. He is the Clinical Lead for the CAR-T Cell Program at Columbia, a principal investigator at the Columbia Center for Translational Immunology and a member of the Herbert Irving Comprehensive Cancer Center.

Biography: Prakash Satwani, MD specializes in the use of bone marrow transplantation to treat children and adolescents with leukemia, lymphoma, or hemophagocytic lymphohistiocytosis. Bone marrow transplantation is a dynamic, intriguing field with multiple complex issues. Dr. Satwani has always enjoyed solving puzzles and is attracted to the intellectual challenge of caring for patients whose lives may be saved or extended with bone marrow transplantation. Dr. Satwani is also inspired and motivated by the long-lasting and rich relationships formed with patients and their families, and often keeps in touch with families long after their child's treatment has been completed. Dr. Satwani teaches medical students, residents, fellows, nurses, and nurse practitioners about bone marrow transplantation. It's important to educate people so they can learn the latest advances and provide the best care possible for patients. To continue to achieve those advances, Dr. Satwani conducts clinical research in reducing the life-threatening complications related to transplantation, such as infections and graft-versus-host disease. Dr. Satwani and colleagues also evaluate reduced-intensity bone marrow transplantation preparative regimens, which use lower doses of chemotherapy with the hope of decreasing short-term and long-term complications without compromising the effectiveness of treatment.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.